Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-137.12%Cash Return on Invested Capital
VS
Market
Sector
Industry
History
$ 2.97Close
$ 1.42 - $ 24.24 52-Week Range
Ticker Information
Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQX4 PHARMACEUTICALS INC - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XFOR - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | -137.12% | $ -112.43M | $ 82M |
| 3/31/2025 | -118.77% | $ -119.94M | $ 100.98M |
| 12/31/2024 | -137.9% | $ -138.23M | $ 100.23M |
| 9/30/2024 | -96.48% | $ -132.97M | $ 137.82M |
| 6/30/2024 | -69.31% | $ -119.69M | $ 172.68M |
| 3/31/2024 | -174.85% | $ -103.71M | $ 59.31M |
| 12/31/2023 | -88.29% | $ -96.57M | $ 109.38M |
| 9/30/2023 | -69.84% | $ -87.92M | $ 125.88M |
| 6/30/2023 | -82.75% | $ -86.4M | $ 104.41M |
| 3/31/2023 | -94.21% | $ -83.47M | $ 88.61M |
Key Performance Insights, Last 5 Years
- X4 PHARMACEUTICALS INC's latest trailing twelve months (TTM) CROIC stands at -42.84%.
- Over the past 5 years, X4 PHARMACEUTICALS INC's average CROIC has been -86.61%.
- The median CROIC for X4 PHARMACEUTICALS INC during this period was -79.64%
- X4 PHARMACEUTICALS INC reached its highest CROIC over the past 5 years at -42.84%.
- The lowest CROIC recorded by X4 PHARMACEUTICALS INC in the same timeframe -174.85%
X4 PHARMACEUTICALS INC's CROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CROIC Benchmarks
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for X4 PHARMACEUTICALS INC is calculated as follows: FCF [ $ -51.7M ] / Inv. Capital [ $ 120.68M ]
(=) CROIC [ -42.84% ] XFOR - Cash Return on Invested Capital, Last 5 years
-174.85%
Minimum
Mar 31, 2024
-42.84%
Maximum
Sep 30, 2020
-86.61%
Average
-79.64%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.78% with a standard deviation of 15.04%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.78% |
| max | 49.3% |
| average | 2.78% |
| median | 4.97% |
| std | 15.04% |